Morning Homed Blood Pressure Trial in elderly hypertensive patients with olmesartan medoxomil compared to azilsartan - Morning Homed Blood Pressure Trial in elderly hypertensive patients with olmesartan medoxomil compared to azilsartan (MHBP trial)

Daiichi-Sankyo Co., Ltd.0 个研究点目标入组 200 人开始时间: 2016年1月14日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. History of hypersensitivity to test drugs 2. Secondary hypertension 3. Grade 3 hypertension (SBP >= 180mmHg and/or DBP >= 110mmHg) 4. Pregnant, possible to pregnancy, or patients who desire pregnancy 5. Taking ARB or ACE inhibitors (excluding taking these drugs more than 3 months before obtaining informed consent) 6. Taking aliskiren fumarate 7. Having serious renal dysfunction (serum creatinine >= 3.0mg/dL) 8. Having serious liver dysfunction 9. Developed cerebral hemorrhage or cerebral infarction within one year before obtaining informed consent 10. Developed myocardial infarction within one year before obtaining informed consent 11. Had a treatment of malignant tumor within 5 years before obtaining informed consent 12. undergoing hemodialysis treatment 13. Any those the investigator or other researchers consider as unsuitable

发起方

Daiichi-Sankyo Co., Ltd.